More on MEDS
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.62 |
|
|||
| Open | $1.62 | ||||
| 52 Wk High | $2.80 | ||||
| 52 Wk Low | $0.08 | ||||
| Day High | $1.62 | ||||
| Day Low | $1.62 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 54,690,766 | ||||
- DataMEDS acquires Helomics cancer diagnostics business for $1.5M
- DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute
- Axe Compute sells cancer diagnostics unit to DataMEDS in all-stock deal
- Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform
- Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout
- CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
- DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
- Form 8-K DataMeds AI, Inc. For: Aug 17
- DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
- Form 10-Q DataMeds AI, Inc. For: Jun 30
Entities mentioned with MEDS
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Stock Buyback | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- S1 | View Related Stories »
- S3 | View Related Stories »
- Show More...
